Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
YCT-529 by YourChoice Therapeutics for Male Contraception: Likelihood of Approval
YCT-529 is under clinical development by YourChoice Therapeutics and currently in Phase II for Male Contraception. According to GlobalData, Phase...